Nucleic acid construct containing fulllength genome of human...

Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S069100, C435S239000, C435S320100, C536S023720, C424S228100, C424S093100, C424S093200, C424S093600

Reexamination Certificate

active

07659103

ABSTRACT:
The present invention provides a method for replicating efficiently an RNA containing fulllength HCV genomic sequence and a method for producing HCV virus particles containing fulllength HCV replicon RNA or fulllength HCV genomic RNA by using a cell culture system. Further, the present invention relates to a method for producing hepatitis C virus particles which comprises culturing a cell, into which a replicon RNA comprising a nucleotide sequence comprising a fulllength genomic RNA sequence of hepatitis C virus of the genotype 2a, at least one selectable marker gene and/or at least one reporter gene and at least one IRES sequence or the fulllength genomic RNA of hepatitis C virus of the genotype 2ais introduced, and generating virus particles in the culture medium. Still further the present invention relates also to a hepatitis C vaccine and an antibody against hepatitis C virus particles.

REFERENCES:
patent: 5428145 (1995-06-01), Okamoto et al.
patent: 6630343 (2003-10-01), Bartenschlager
patent: 2003/0009775 (2003-01-01), Glenn
patent: 6-121689 (1994-05-01), None
patent: 2002-171978 (2002-06-01), None
patent: WO-00/75337 (2000-12-01), None
patent: WO-00/75338 (2000-12-01), None
patent: WO-2004/044182 (2004-05-01), None
Hadlock et al., “Human Monoclonal Antibodies That Inhibit Binding of Hepatitis C Virus E2 Protein to CD81 and Recognize Conserved Conformational Epitopes,” Journal of Virology, vol. 74 No. 22, pp. 10407-10416 (Nov. 2000).
Kato et al., “Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient,” Journal of Medical Virology, vol. 64 No. 3, pp. 334-339 (Jul. 2001).
Blanchard et al. “Hepatitis C virus-like particle morphogenesis,” Journal of Virology, vol. 76 No. 8, pp. 4073-4079 (Apr. 2002).
GenBank AB114136, “Hepatitis C virus replicon pSGR-JFH1 gene for neomysin resistance gene product, hepatitis C virus nonstructural protein, complete cds.” (first avail Jan. 2004).
Ciccarone et al., “pSFV1 Eukaryotic Expression Vector: A Novel Protein Expression System,” Focus 15:103-105, Life Technologies, Inc. (1993).
Date et al., “An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain,” Hepatology Research, vol. 37 No. 6, pp. 433-443 (Epub Apr. 2007).
Meunier et al., “Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1,” Proceedings of the National Academy of Sciences, USA, vol. 102 No. 12, pp. 4560-4565 (Epub Mar. 2005).
Pietschmann et al., “Persistent and Transient Replication of Full-Length Hepatitis C Virus Genomes in Cell Culture,” Journal of Virology, vol. 76 No. 8, pp. 4008-4021 (Apr. 2002).
Gottwein et al., “Robust Hepatitis C Genotype 3a Cell Culture Releasing Adapted Intergenotypic 3a/2a (S52/JFH1) Viruses,” Gastroenterology, vol. 133 No. 5, pp. 1614-1626 (Nov. 2007).
Mateu et al., “Intragenotypic JFH1 based recombinant hepatitis C virus produces high levels of infectious particles but causes increased cell death,” Virology, vol. 376 No. 2, pp. 397-407 (Epub May 2008).
Sequence alignment, Seq Id No. 12 and Seq Id No. 2 from copending U.S. Appl. No. 11/898,468, Nov. 18, 2008.
Ikeda et al., Journal of Virology, vol. 76, No. 6, pp. 2997-3006, (Mar. 2002).
Lim et al., Virology, vol. 303, pp. 79-99, (2002).
Lechmann et al., Hepatology, pp. 417-423, (Aug. 2001).
Scholle et al., Journal of Virology, vol. 78 No. 3, pp. 1513-1524, (Feb. 2004). XP-002417178.
Lohmann et al. Science, vol. 285 pp. 110-113, (Jul. 1999). XP-000960693.
Kato et al., Gastroenterology, vol. 125, No. 6, pp. 1808-1817, (Dec. 2003). XP-002394801.
Friebe et al. Journal Of Virology, vol. 75, No. 24, pp. 12047-12057, (Dec. 2001). XP-002977108.
Kimura et al., “Antibody-Free Virion Titer Greatly Differs Between Hepatitis C Virus Genotypes,” Journal of Medical Virology, vol. 61, pp. 37-43, (2000).
Date et al., The Journal of Biological Chemistry, vol. 279, No. 21, pp. 22371-22376, 2004.
EMBL Accession No. AB047639, Feb. 25, 2001.
Genbank [online]; National Center for Bio technology Information, Bethesda MD, USA, [retrieved on Dec. 15, 2004], Retrieved from the Internet: URL:http://www.ncbi.nlm.nih.gov:80/entrez/viewerfcgi?list—uids=13122273>, Accession No. AB047645.
Takanobu Kato, Japan Health Sciences Foundation, pp. 14 to 19, Figs.1 p. 18.
Database EMBL [online]; Feb. 25, 2001, Accession No. EM—VI: AB047644, XP002394805.
Database EMBL [online]; Jan. 17, 2001, Accession No. EM—VI: AF169002, XP002394806.
Kurihara C. et al., J. Med. Virol., vol. 64, pp. 466-475, (2001).
Database EMBL [online]; Jan. 17, 2001, Accession No. EM—PAT: AX057317, XP002394807.
Simmonds, P. et al., Hepatology, vol. 19, No. 5, pp. 1321-1324 (May 1994).
Choo, Q. L. et al., Science, vol. 244, pp. 359-362, (Apr. 21, 1989).
Okamoto, H. et al., J. of Gen. Virol., vol. 73, pp. 673-679, (1992).
Yoshioka, K. et al., Hepatology, vol. 16, No. 2, pp. 293-299, (1992).
Mori, S. et al., Biochemical and Biophysical Research Communications, vol. 183, No. 1, pp. 334-342, (Feb. 28, 1992).
Blight, K. et al., Science, vol. 290, pp. 1972-1975, (Dec. 8, 2000).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Nucleic acid construct containing fulllength genome of human... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid construct containing fulllength genome of human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid construct containing fulllength genome of human... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4213355

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.